What is Nuubo?
Nuubo is at the forefront of disruptive healthcare technology, specializing in non-invasive, wireless monitoring solutions based on textiles. Their advanced aECG technology enables medium and long-term remote cardiac monitoring, offering healthcare professionals a novel perspective with high predictability and flexibility. Designed for patient comfort and ease of use, Nuubo's system promotes high compliance levels, ensuring the collection of critical cardiac data through textile electrodes engineered for optimal ECG signal quality during daily activities.
How much funding has Nuubo raised?
Nuubo has raised a total of $4M across 1 funding round:
Unspecified
$4M
Unspecified (2014): $4M with participation from Fides Capital and CRB Inverbu00edo
Key Investors in Nuubo
Fides Capital
Fides Capital Partners is a real estate advisory and investment firm that focuses on creating and capitalizing on opportunities by aligning capital partners with best-in-class asset owners, emphasizing integrity and trust in its advisory and investment services.
CRB Inverbu00edo
CRB Inverbio is a private venture capital management firm specializing in life sciences, focusing on innovative early-stage startups in biotech, med tech, digital health, and medical technologies, providing advisory services and strategic financing options.
What's next for Nuubo?
The recent major strategic investment in Nuubo signals a pivotal growth phase, likely aimed at scaling its innovative textile-based cardiac monitoring technology. This capital infusion is expected to accelerate market penetration, further research and development into advanced diagnostic capabilities, and potentially expand its global reach. Nuubo's focus on patient comfort and high compliance positions it for significant expansion within the rapidly growing remote patient monitoring market, attracting further investment as it solidifies its position as a leader in flexible and effective cardiac care solutions.
See full Nuubo company page
